 incid determin signific delay clearanc serum hbsag chronic hepat viru infect prospect studi incid determin signific delay clearanc serum hbsag chronic hepat viru infect prospect follow-up studi consecut group patient group patient men women biopsy-proven chronic type hepat group II asymptomat chronic carrier men women normal serum aminotransferas activ mean follow-up period yr patient group hbsag serum wherea patient group II mean follow-up period yr annual incid delay serum hbsag clearanc group group II cumul probabl hbsag clearanc group II group hbsag patient chronic hepat asymptomat carrier serum hbsag hbeag neg entri cirrhosi follow-up incid delay hbsag clearanc gender initi histolog chang hepat delta viru infect occurr hbsag clearanc serum hbv dna detect slot-blot hybrid detect polymeras chain reaction serum specimen yr hbsag clearanc liver biopsi patient signific hepat activ tissu hbv dna hbsag hbcag